STAT News
On Extra Extra, STAT News is grouped with center outlets, a placement drawn from the consensus of independent media-bias raters (AllSides, Ad Fontes Media, and Media Bias/Fact Check) rather than our own opinion. Its reliability rating of A reflects a strong track record of factual, well-sourced reporting. That rating is a guide for weighing what you read here, not a verdict on any single article.
We are currently tracking 8 recent articles from STAT News, published over the past 3 days. Recurring themes in its latest headlines include Stat, Scientist, David, Sabatini, and Cambridge.
The best way to use this profile is comparatively. Read STAT News's coverage of a story alongside how outlets on other parts of the spectrum handle the same event — the facts usually overlap, but the emphasis, language, and what gets left out often do not. Other center sources we track include BBC News, Al Jazeera, Associated Press, and Reuters.
Recent Articles (8)
STAT+: Cambridge scientist David Sabatini speaks out after courtroom victory: ‘The hardest years of my life’
"The hardest years of my life," is how Cambridge scientist David Sabatini describes the time since his downfall from MIT.
STAT+: Jury rules in favor of ousted Cambridge scientist David Sabatini, with $6 million in damages to be awarded
A jury awarded $6 million in damages to scientist David Sabatini, whose career imploded after he was accused by a much younger colleague of inappropriate sexual conduct in his lab.
Hospitals’ next lucrative bet — longevity clinics
On this week's “The Readout LOUD,” STAT's biotech podcast, we discuss the booming industry of longevity health.
STAT+: Up and down the ladder: The latest comings and goings
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
STAT+: Pharmalittle: We’re reading about an HHS peptide push, Trump’s pharma stock holdings, and more
The Trump administration is proceeding with a plan to allow compounding pharmacies to produce certain peptides
STAT+: RevMed’s pancreatic cancer drug nears European approval
Following a green light from the FDA, European regulators have now recommended the approval of Revolution Medicines' Rasonque for pancreatic cancer.
What to read before you go see that new documentary on Elizabeth Holmes
Ahead of "You Can See Everything" hitting theaters, let's rewind the last decade and review some of the most significant news tied to Elizabeth Holmes, who was convicted in 2022…
STAT+: Coerced sex or a jealous ex? Jury weighs dueling accounts of star scientist David Sabatini’s downfall
Was molecular biologist David Sabatini a manipulative mentor who coerced a younger colleague into sex? Or was he the victim of a spurned former lover?